Business
Why the Race Oncology (ASX:RAC) share price is racing higher
The Race Oncology Ltd (ASX: RAC) share price is climbing today after an update from the Aussie healthcare company.
Why is the Race Oncology share price climbing?
Race Oncology announced that it has entered into a collaborative preclinical research program with The University of Newcastle. The purpose of the program is to investigate the heart safety Bisantrene offers over current anthracycline therapeutics.
Bisantrene is Race Oncology’s Phase 2/3 cancer drug that is a “potent inhibitor” of the Fatso/Fat mass and obesity-associated (FTO) protein. The possible role of FTO inhibition in Bisantrene’s lack of cardiotoxicity will be a primary focus of the new project.
The Race Oncology share price has jumped 1.6% higher at…
-
Noosa News24 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
General10 hours agoGrieving parents of 4yo boy who drowned in Officer suing Melbourne Water, Cardinia council
-
Noosa News5 hours agoSES celebrates 50 years | Noosa Today
-
Noosa News19 hours agoWhat are Medicare Mental Health Centres, and what do they offer?